Close
CDMO Safety Testing 2026
Novotech

ChargePoint Technology and Famat Sampling partner up to create robust containment solution for HPAPI powder transfer

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.
- Advertisement -

Powder transfer specialist, ChargePoint Technology has joined forces with sampling device specialist, Famat Sampling, to tackle one of the industryโ€™s most challenging containment problems. The pharmaceutical suppliers have created an integrated valve solution capable of allowing operators to take a product sample during the course of the production process for quality analysis while maintaining optimum containment and sterile integrity.ย 

The powerful combination of ChargePoint Technologyโ€™s split butterfly valve and Famat Samplingโ€™s 125-TC/OEL valve creates a secure and sterile environment for high- potency and sterile powder samples to be taken. The interconnected system forms an airtight seal that prevents a dead zone and allows samples of highly potent, toxic or sterile powders to be transferred into containers safely and securely, maintaining OEB4 and OEB5 level compliance.ย 

The integrated network of valves allow for rigorous testing capabilities and ensure that product quality is maintained during the process and it is FDA compliant. The combination of products help minimise risk to the operator, who could be exposed to potentially dangerous powders during the sampling process.ย 

The powder product must not be altered during sampling, as oxygen or other particles could come into contact during the extraction process and damage the product. The combination of technologies from ChargePoint Technology and Famat acts as an isolator and offers users a safe method of transfer so the quality of the product can be protected.ย 

Christian Dunne, Head of Sterile Solutions at ChargePoint Technology, commented on the partnership: โ€œThe HPAPI market is predicted to grow by 8.7%ย  to reach a value of $34.97 billion by 2028 (1), highlighting why itโ€™s vital for drug manufacturers to invest in appropriate containment technologies, as while ensuring they are able to maintain optimum product quality.ย 

โ€œDuring processing, manufacturers must prioritise sampling so that the quality of drug products can be assessed at various stages of the production process. Famat Sampling shares our high standards for quality. Joining forces as two recognised industry leaders in our respective fields was a no-brainer for our team.ย 

โ€œOur shared depth and breadth of knowledge and experience have allowed us to create a solution that helps solve a prevalent issue for manufacturers and adds additional protection for users.โ€ย 

ChargePoint Technology offers containment and aseptic transfer valves and single-use solutions that are essential for the safe transfer of powders during pharmaceutical and biopharmaceutical manufacturing.

Latest stories

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป